CABG boosts outcomes in diabetes plus multivessel CAD

11/4/2012 | Healio

Data on 1,900 patients with diabetes and multivessel coronary artery disease showed those who underwent coronary artery bypass grafting had lower rates of all-cause mortality, nonfatal myocardial infarction or nonfatal stroke at five years compared with those who had percutaneous coronary intervention with a drug-eluting stent. Lower rates of cardiovascular and cerebrovascular events were also seen in the CABG group, researchers said. The results were presented at the American Heart Association meeting.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA